Phoenix Biotech Acquisition Corp. carries a market capitalization of 36.47M, placing it among publicly traded companies globally.
| Market Cap | 36.47M |
| Enterprise Value | N/A |
Phoenix Biotech Acquisition Corp.'s stock has declined approximately -45.22472% over the past 52 weeks. The 50-day moving average sits at 10.39, while the 200-day moving average is 10.74.
| Beta (5Y) | N/A |
| 52-Week Price Change | -45.22472% |
| 50-Day Moving Average | 10.39 |
| 200-Day Moving Average | 10.74 |
| Average Volume (20 Days) | N/A |